FDA Inspection 1321538 — Recordati AG, Rare Diseases Branch
The FDA completed an inspection of Recordati AG, Rare Diseases Branch on Jul 24, 2024 in Basel Town. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 24, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Basel Town (Switzerland)
Additional Details
Mutual Recognition Agreement (MRA)